Citizens JMP Reiterates Market Outperform Rating on Altimmune (ALT)
Tweet Send to a Friend
(Updated - April 2, 2025 4:38 AM EDT)
Citizens JMP analyst Jonathan Wolleben reiterated a Market Outperform rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citizens JMP analyst Jonathan Wolleben reiterated a Market Outperform rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
